MEK and the inhibitors: from bench to bedside

Published 2013 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
MEK and the inhibitors: from bench to bedside
Authors
Keywords
Melanoma, Docetaxel, Papillary Thyroid Cancer, Malignant Mesothelioma, Vemurafenib
Journal
Journal of Hematology & Oncology
Volume 6, Issue 1, Pages 27
Publisher
Springer Nature
Online
2013-04-12
DOI
10.1186/1756-8722-6-27

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.